Clinical Trial Update: Phase II Non-Randomized Study Evaluating POSLUMA-PSMA PET Response After Oligo- Metastatic/Progressive-directed Treatment With Radiotherapy (PROMPT-R) [Phase 2]

View source ↗

Summary

Phase II non-randomized trial evaluating POSLUMA-PSMA PET response after radiotherapy-directed treatment in oligometastatic or progressive prostate cancer, curr…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• POSLUMA-PSMA PET

Snippet

Sponsor: City of Hope Medical Center | Conditions: Prostate Cancer | Phase 2 | Status: RECRUITING